Connect Biopharma Holdings Limited

NasdaqGM:CNTB Stock Report

Market Cap: US$83.8m

Connect Biopharma Holdings Balance Sheet Health

Financial Health criteria checks 5/6

Connect Biopharma Holdings has a total shareholder equity of $101.0M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $125.9M and $24.8M respectively.

Key information

0%

Debt to equity ratio

US$0

Debt

Interest coverage ration/a
CashUS$118.70m
EquityUS$101.04m
Total liabilitiesUS$24.85m
Total assetsUS$125.89m

Recent financial health updates

Recent updates

Companies Like Connect Biopharma Holdings (NASDAQ:CNTB) Are In A Position To Invest In Growth

Mar 07
Companies Like Connect Biopharma Holdings (NASDAQ:CNTB) Are In A Position To Invest In Growth

Is Connect Biopharma Holdings (NASDAQ:CNTB) In A Good Position To Invest In Growth?

Sep 19
Is Connect Biopharma Holdings (NASDAQ:CNTB) In A Good Position To Invest In Growth?

Will Connect Biopharma Holdings (NASDAQ:CNTB) Spend Its Cash Wisely?

Mar 29
Will Connect Biopharma Holdings (NASDAQ:CNTB) Spend Its Cash Wisely?

Is Connect Biopharma Holdings (NASDAQ:CNTB) In A Good Position To Deliver On Growth Plans?

Dec 14
Is Connect Biopharma Holdings (NASDAQ:CNTB) In A Good Position To Deliver On Growth Plans?

Market Appears To Relegate Connect Biopharma To A Long-Term Hold

Oct 10

Connect Biopharma Is A Sleeper Heading Into October Data Readout

Sep 26

Connect Biopharma reports 1H results

Sep 13

We're Keeping An Eye On Connect Biopharma Holdings' (NASDAQ:CNTB) Cash Burn Rate

Aug 12
We're Keeping An Eye On Connect Biopharma Holdings' (NASDAQ:CNTB) Cash Burn Rate

We're Keeping An Eye On Connect Biopharma Holdings' (NASDAQ:CNTB) Cash Burn Rate

Apr 29
We're Keeping An Eye On Connect Biopharma Holdings' (NASDAQ:CNTB) Cash Burn Rate

Connect Biopharma's Latest Dermatitis Drug Update Fails To Pump Up Shares

Jan 12

We're Hopeful That Connect Biopharma Holdings (NASDAQ:CNTB) Will Use Its Cash Wisely

Jan 01
We're Hopeful That Connect Biopharma Holdings (NASDAQ:CNTB) Will Use Its Cash Wisely

Financial Position Analysis

Short Term Liabilities: CNTB's short term assets ($121.0M) exceed its short term liabilities ($24.3M).

Long Term Liabilities: CNTB's short term assets ($121.0M) exceed its long term liabilities ($585.0K).


Debt to Equity History and Analysis

Debt Level: CNTB is debt free.

Reducing Debt: CNTB currently has no debt however we can't compare to 5 years ago as we have no data for that period.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: CNTB has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if CNTB has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Discover healthy companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.